发明名称 |
Multimeric polypeptides of HLA-G including alpha1-alpha3 monomers and pharmaceutical uses thereof |
摘要 |
Multimeric polypeptides and pharmaceutical uses thereof; multimers comprising alpha3 and alpha1 peptides of an HLA-G antigen and methods of producing such multimers, pharmaceutical compositions comprising the same, as well as their uses for treating various diseases including organ/tissue rejection. Said multimers comprise at least two monomers, each of said monomers being selected in the group consisting of a peptide P2 of formula P1-X3 or X2-X3, wherein P1 is of formula X1-X2, wherein X1 represents a peptidic linker including a cysteine amino acid and X2 represents an alpha1 domain (or alpha1 peptide) of HLA-G and X3 represents an alpha3 domain of HLA-G. |
申请公布号 |
US9359424(B2) |
申请公布日期 |
2016.06.07 |
申请号 |
US201013380659 |
申请日期 |
2010.06.25 |
申请人 |
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES |
发明人 |
Le Maoult Joel;Carosella Edgardo Delfino |
分类号 |
A61K39/00;C07K14/74 |
主分类号 |
A61K39/00 |
代理机构 |
Oblon, McClelland, Maier & Neustadt, L.L.P. |
代理人 |
Oblon, McClelland, Maier & Neustadt, L.L.P. |
主权项 |
1. A multimer, comprising:
at least two monomers each selected from the group consisting of a peptide P2 consisting of formula P1-X3 and a peptide P2 consisting of formula X2-X3, wherein P1 is a peptide of formula X1-X2, X1 represents a peptidic linker X1 comprising at least 10 and up to 100 amino acids, and the peptidic linker X1 comprising cysteine at or in position 4 or less from the N-terminal end thereof, X2 represents an alpha1 domain of HLA-G, and X3 represents an alpha3 domain of HLA-G. |
地址 |
Paris FR |